SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-16-004671
Filing Date
2016-03-29
Accepted
2016-03-29 16:20:34
Documents
88
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K s102655_10k.htm 10-K 1607751
2 EXHIBIT 21.1 s102655_ex21-1.htm EX-21.1 3133
3 EXHIBIT 23-1 s102655_ex23-1.htm EX-23.1 2941
4 EXHIBIT 31-1 s102655_ex31-1.htm EX-31.1 9941
5 EXHIBIT 31-2 s102655_ex31-2.htm EX-31.2 9294
6 EXHIBIT 32-1 s102655_ex32-1.htm EX-32.1 3261
7 EXHIBIT 32-2 s102655_ex32-2.htm EX-32.2 3252
8 GRAPHIC tpg7.jpg GRAPHIC 52145
  Complete submission text file 0001615774-16-004671.txt   8117376

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE heb-20151231.xml EX-101.INS 1862260
10 XBRL SCHEMA FILE heb-20151231.xsd EX-101.SCH 65364
11 XBRL CALCULATION FILE heb-20151231_cal.xml EX-101.CAL 61240
12 XBRL DEFINITION FILE heb-20151231_def.xml EX-101.DEF 381480
13 XBRL LABEL FILE heb-20151231_lab.xml EX-101.LAB 488303
14 XBRL PRESENTATION FILE heb-20151231_pre.xml EX-101.PRE 486625
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27072 | Film No.: 161535618
SIC: 2836 Biological Products, (No Diagnostic Substances)